Carolinas Wealth Consulting LLC Abb Vie Inc. Transaction History

Carolinas Wealth Consulting LLC

$577 Million
Q3 2024

A detailed history of Carolinas Wealth Consulting LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Carolinas Wealth Consulting LLC holds 10,708 shares of ABBV stock, worth $1.93 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

10,708

Previous 10,247 4.5%

Holding current value

$1.93 Million

Previous $1.76 Million 20.32%

% of portfolio

0.37%

Previous 0.32%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$163.84 - $199.33 $75,530 - $91,891	461 Added 4.5%	10,708 $2.11 Million
Q2 2024 Aug 12, 2024	BUY	$154.79 - $180.76 $338,835 - $395,683	2,189 Added 27.17%	10,247 $1.76 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $2.48 Million - $2.82 Million	-15,488 Reduced 65.78%	8,058 $1.47 Million
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $20,915 - $23,555	152 Added 0.65%	23,546 $3.65 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $16,698 - $19,331	125 Added 0.54%	23,394 $3.49 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $86,131 - $107,185	-650 Reduced 2.72%	23,269 $3.14 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $56,108 - $64,617	388 Added 1.65%	23,919 $3.81 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $442,038 - $530,120	3,196 Added 15.72%	23,531 $3.81 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $39,055 - $44,793	-291 Reduced 1.41%	20,335 $675,000
Q2 2022 Aug 16, 2022	BUY	$137.62 - $174.96 $2.08 Million - $2.64 Million	15,086 Added 272.31%	20,626 $812,000
Q1 2022 May 17, 2022	BUY	$131.98 - $163.75 $19,005 - $23,580	144 Added 2.67%	5,540 $898,000
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $61,987 - $78,431	577 Added 11.97%	5,396 $731,000
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $111,932 - $127,060	-1,052 Reduced 17.92%	4,819 $520,000
Q2 2021 Aug 17, 2021	BUY	$105.21 - $117.21 $78,171 - $87,087	743 Added 14.49%	5,871 $661,000
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $54,321 - $59,801	531 Added 11.55%	5,128 $555,000
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $67,450 - $91,065	838 Added 22.29%	4,597 $493,000
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $36,339 - $42,651	423 Added 12.68%	3,759 $329,000
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $807 - $1,079	11 Added 0.33%	3,336 $328,000
Q1 2020 May 11, 2020	BUY	$64.5 - $97.79 $214,462 - $325,151	3,325 New	3,325 $253,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carolinas Wealth Consulting LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carolinas Wealth Consulting LLC with notifications on news.

Account

Carolinas Wealth Consulting LLC Abb Vie Inc. Transaction History